(1)
Nan, D.; Abraira-Meriel, C.; de la Roz-Fernandez, S.; Maestre-Orozco, T.; Hernandez, J. L.; Fernandez-Ayala, M. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients With Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. EJCRIM 2021, 8.